Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Net Income: 2009-2024

Historic Net Income for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $223.4 million.

  • Select Medical Holdings' Net Income fell 5494.98% to $14.2 million in Q4 2024 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year decrease of 9382.87%. This contributed to the annual value of $223.4 million for FY2024, which is 792.06% down from last year.
  • Select Medical Holdings' Net Income amounted to $223.4 million in FY2024, which was down 792.06% from $242.6 million recorded in FY2023.
  • Select Medical Holdings' 5-year Net Income high stood at $499.9 million for FY2021, and its period low was $223.4 million during FY2024.
  • Over the past 5 years, Select Medical Holdings' median Net Income value was $242.6 million (recorded in 2023), while the average stood at $307.2 million.
  • In the last 5 years, Select Medical Holdings' Net Income soared by 7141.93% in 2020 and then crashed by 5493.32% in 2022.
  • Over the past 5 years, Select Medical Holdings' Net Income (Annual) stood at $344.6 million in 2020, then soared by 45.08% to $499.9 million in 2021, then crashed by 54.93% to $225.3 million in 2022, then increased by 7.69% to $242.6 million in 2023, then fell by 7.92% to $223.4 million in 2024.
  • Its last three reported values are $223.4 million in FY2024, $242.6 million for FY2023, and $225.3 million during FY2022.